Literature DB >> 28124192

HIV Risk Perception and Risky Behavior Among People Who Inject Drugs in Kermanshah, Western Iran.

Mehdi Noroozi1, Elahe Ahounbar1, Salah Eddin Karimi1, Sina Ahmadi1, Mohammad Najafi1, Ali Bazrafshan1, Zahra Jorjoran Shushtari1, Mohammad Hassan Farhadi1, Peter Higgs1, Fatemeh Rezaei1, Hesam Ghiasvand1, Asaad Sharhani1, Bahram Armoon2, Katherine Waye1.   

Abstract

PURPOSE: Understanding and increasing awareness on individual risk for HIV infection as well as HIV risk perception's effects on different behavioral outcomes for people who inject drugs (PWID) is important for policymaking and planning purposes. The objectives of the present study were to determine whether HIV risk perception was associated with greater injection and sexual risk-taking behaviors among PWIDs.
METHOD: We surveyed 460 PWID in Kermanshah regarding their demographic characteristics, sexual risk behaviors, HIV risk perception, and drug-related risk behaviors in the month prior to the study. Three classes of HIV risk perception were identified using ordinal regression to determine factors associated with HIV risk perception.
RESULTS: Study participants were categorized as follows: "low" (n = 100, 22%), "moderate" (n = 150, 32%), and "high" (n = 210, 46%) risk perception for becoming infected with HIV. The odds of categorizing as "high" risk for HIV was significantly greater in PWID that reported unprotected sex (adjusted odds ratio (AOR) 2.4, p value 0.02), receptive syringe sharing (AOR 1.8, p value 0.01), and multiple sex partners (AOR 1.4, p value 0.03). PWID who reported unprotected sex had 2.7 times the odds of "high" risk perception when compared to PWID with "low" risk perception.
CONCLUSION: Findings show that PWID could rate their HIV risk with acceptable accuracy. Additionally, perceived HIV risk was associated with many risk factors for transmission of HIV, emphasizing the importance of developing targeted prevention and harm reduction programs for all domains of risk behaviors, both sexual and drug-related use.

Entities:  

Keywords:  HIV risk perception; Inject drugs; Risky behavior

Mesh:

Year:  2017        PMID: 28124192     DOI: 10.1007/s12529-017-9634-7

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  19 in total

1.  Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation.

Authors:  Catherine M Lowndes; Michel Alary; Lucy Platt
Journal:  Sex Transm Dis       Date:  2003-01       Impact factor: 2.830

2.  Centers for Disease Control and Prevention revised guidelines for human immunodeficiency virus (HIV) counseling, testing, and referral: targeting HIV specialists.

Authors:  William G Powderly; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2003-08-23       Impact factor: 9.079

Review 3.  Can HIV epidemics among injection drug users be prevented?

Authors:  S A Strathdee; E J van Ameijden; F Mesquita; A Wodak; S Rana; D Vlahov
Journal:  AIDS       Date:  1998       Impact factor: 4.177

4.  Measuring risk perceptions of skin cancer: reliability and validity of different operationalizations.

Authors:  Eva Janssen; Liesbeth van Osch; Hein de Vries; Lilian Lechner
Journal:  Br J Health Psychol       Date:  2011-02

5.  HIV prevention among male clients of female sex workers in Kaolack, Senegal: results of a peer education program.

Authors:  L Leonard; I Ndiaye; A Kapadia; G Eisen; O Diop; S Mboup; P Kanki
Journal:  AIDS Educ Prev       Date:  2000-02

6.  Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men: opportunities for advancing HIV prevention in the third decade of HIV/AIDS.

Authors:  Duncan A MacKellar; Linda A Valleroy; Gina M Secura; Stephanie Behel; Trista Bingham; David D Celentano; Beryl A Koblin; Marlene Lalota; William McFarland; Douglas Shehan; Hanne Thiede; Lucia V Torian; Robert S Janssen
Journal:  J Acquir Immune Defic Syndr       Date:  2005-04-15       Impact factor: 3.731

7.  The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.

Authors:  Seyed Saeed Hashemi Nazari; Mehdi Noroozi; Hamid Soori; Alireza Noroozi; Yadollah Mehrabi; Ahmad Hajebi; Hamid Sharifi; Peter Higgs; Ali Mirzazadeh
Journal:  Int J Drug Policy       Date:  2015-11-12

8.  HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.

Authors:  Afarin Rahimi-Movaghar; Emran M Razaghi; Elaheh Sahimi-Izadian; Masoumeh Amin-Esmaeili
Journal:  Int J Infect Dis       Date:  2009-05-21       Impact factor: 3.623

9.  Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study.

Authors:  Mohsen Vazirian; Bijan Nassirimanesh; Saman Zamani; Masako Ono-Kihara; Masahiro Kihara; Shahrzad Mortazavi Ravari; Mohammad Mehdi Gouya
Journal:  Harm Reduct J       Date:  2005-10-07

10.  Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran.

Authors:  Mehdi Noroozi; Ali Mirzazadeh; Alireza Noroozi; Yadoallah Mehrabi; Ahmad Hajebi; Saman Zamani; Hamid Sharifi; Peter Higgs; Hamid Soori
Journal:  Addict Health       Date:  2015 Summer-Autumn
View more
  9 in total

1.  Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.

Authors:  Mehdi Noroozi; Alireza Noroozi; Hamid Sharifi; Gholamreza Ghaedamini Harouni; Brandon D L Marshall; Hesam Ghisvand; Mostafa Qorbani; Bahram Armoon
Journal:  Int J Behav Med       Date:  2019-02

2.  Dental caries and periodontal disease among people who use drugs: a systematic review and meta-analysis.

Authors:  Mohsen Yazdanian; Bahram Armoon; Alireza Noroozi; Rasool Mohammadi; Amir-Hosein Bayat; Elahe Ahounbar; Peter Higgs; Hormoz Sanaei Nasab; Azadeh Bayani; Morteza Hemmat
Journal:  BMC Oral Health       Date:  2020-02-10       Impact factor: 2.757

3.  Development and evidence of validity of the HIV risk perception scale for young adults in a Hispanic-American context.

Authors:  Patricio Mena-Chamorro; Rodrigo Ferrer-Urbina; Geraldy Sepúlveda-Páez; Francisca Cortés-Mercado; Carolina Gutierrez-Mamani; Kyara Lagos-Maldonado; María Peña-Daldo
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

4.  Investigating the contributing factors to HIV/AIDS infection from the perspective of HIV-infected patients.

Authors:  Morteza Mehraeen; Mohammadreza Heydari; Kamran B Lankarani; Hassan Joulaei; Marjan Faghih
Journal:  BMC Psychol       Date:  2021-01-25

Review 5.  Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.

Authors:  Abdolhalim Rajabi; Heidar Sharafi; Seyed Moayed Alavian
Journal:  Harm Reduct J       Date:  2021-01-22

6.  Prevalence of mental health conditions among people living with HIV during the COVID-19 pandemic: A rapid systematic review and meta-analysis.

Authors:  Kai Wei Lee; Chin Siang Ang; Sin How Lim; Ching Sin Siau; Lai Teik Derek Ong; Siew Mooi Ching; Pei Boon Ooi
Journal:  HIV Med       Date:  2022-03-18       Impact factor: 3.094

7.  Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran.

Authors:  Salah Eddin Karimi; Nasibeh Zanjari; Neda SoleimanvandiAzar; Elaheh Ahounbar; Mohammad Ali Mohammadi Gharehghani; Sina Ahmadi
Journal:  Med J Islam Repub Iran       Date:  2021-04-28

8.  Decomposing economic disparities in risky sexual behaviors among people who inject drugs in Tehran: Blinder-Oaxaca decomposition analysis.

Authors:  Mehdi Noroozi; Hamid Sharifi; Alireza Noroozi; Fatemah Rezaei; Mohammad Rafi Bazrafshan; Bahram Armoon
Journal:  Epidemiol Health       Date:  2017-11-05

9.  Methamphetamine use and HIV risk behavior among men who inject drugs: causal inference using coarsened exact matching.

Authors:  Mehdi Noroozi; Peter Higgs; Alireza Noroozi; Bahram Armoon; Bentolhoda Mousavi; Rosa Alikhani; Mohammad Rafi Bazrafshan; Ali Nazeri Astaneh; Azadeh Bayani; Ladan Fattah Moghaddam
Journal:  Harm Reduct J       Date:  2020-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.